GlassScriptPhysician profile
Rim Ishak
NPI 1255836409
$3,895.23
in general payments reported to CMS, 2019-2025
8 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $594 · 2022: $2,018 · 2023: $852 · 2024: $226 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257 · Education: $25.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.33 |
| Education | $25.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,000.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $695.03 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $659.13 | 2022-2024 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $546.95 | 2021-2023 | Nucala |
| Aerin Medical INC. | $362.08 | 2022-2024 | |
| Genzyme Corporation | $271.11 | 2022-2023 | |
| Amgen INC. | $254.17 | 2022-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $106.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rim Ishak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.